TY - JOUR
T1 - Syndromes predisposing to leukemia are a major cause of inherited cytopenias in children
AU - Gilad, Oded
AU - Noy-Lotan, Sharon
AU - Krasnov, Tanya
AU - Yacobovich, Joanne
AU - Rabinowicz, Ron
AU - Goldberg, Tracie
AU - Abu-Quider, Abed
AU - Miskin, Hagit
AU - Kapelushnik, Noa
AU - Mandel-Shorer, Noa
AU - Shimony, Shai
AU - Harlev, Dan
AU - Ben-Ami, Tal
AU - Adam, Etai
AU - Levin, Carina
AU - Aviner, Shraga
AU - Elhasid, Ronit
AU - Berger-Achituv, Sivan
AU - Chaitman-Yerushalmi, Lilach
AU - Kodman, Yona
AU - Oniashvilli, Nino
AU - Hameiri-Grosman, Michal
AU - Izraeli, Shai
AU - Tamary, Hannah
AU - Steinberg-Shemer, Orna
AU - Kuperman, Amir A.
N1 - Publisher Copyright: © 2022 Ferrata Storti Foundation.
PY - 2022/9/1
Y1 - 2022/9/1
N2 - Prolonged cytopenias are a non-specific sign with a wide differential diagnosis. Among inherited disorders, cytopenias predisposing to leukemia require a timely and accurate diagnosis to ensure appropriate medical management, including adequate monitoring and stem cell transplantation prior to the development of leukemia. We aimed to define the types and prevalences of the genetic causes leading to persistent cytopenias in children. The study comprises children with persistent cytopenias, myelodysplastic syndrome, aplastic anemia, or suspected inherited bone marrow failure syndromes, who were referred for genetic evaluation from all pediatric hematology centers in Israel during 2016-2019. For variant detection, we used Sanger sequencing of commonly mutated genes and a custom-made targeted next-generation sequencing panel covering 226 genes known to be mutated in inherited cytopenias; the minority subsequently underwent whole exome sequencing. In total, 189 children with persistent cytopenias underwent a genetic evaluation. Pathogenic and likely pathogenic variants were identified in 59 patients (31.2%), including 47 with leukemia predisposing syndromes. Most of the latter (32, 68.1%) had inherited bone marrow failure syndromes, nine (19.1%) had inherited thrombocytopenia predisposing to leukemia, and three each (6.4%) had predisposition to myelodysplastic syndrome or congenital neutropenia. Twelve patients had cytopenias with no known leukemia predisposition, including nine children with inherited thrombocytopenia and three with congenital neutropenia. In summary, almost one third of 189 children referred with persistent cytopenias had an underlying inherited disorder; 79.7% of whom had a germline predisposition to leukemia. Precise diagnosis of children with cytopenias should direct follow-up and management programs and may positively impact disease outcome.
AB - Prolonged cytopenias are a non-specific sign with a wide differential diagnosis. Among inherited disorders, cytopenias predisposing to leukemia require a timely and accurate diagnosis to ensure appropriate medical management, including adequate monitoring and stem cell transplantation prior to the development of leukemia. We aimed to define the types and prevalences of the genetic causes leading to persistent cytopenias in children. The study comprises children with persistent cytopenias, myelodysplastic syndrome, aplastic anemia, or suspected inherited bone marrow failure syndromes, who were referred for genetic evaluation from all pediatric hematology centers in Israel during 2016-2019. For variant detection, we used Sanger sequencing of commonly mutated genes and a custom-made targeted next-generation sequencing panel covering 226 genes known to be mutated in inherited cytopenias; the minority subsequently underwent whole exome sequencing. In total, 189 children with persistent cytopenias underwent a genetic evaluation. Pathogenic and likely pathogenic variants were identified in 59 patients (31.2%), including 47 with leukemia predisposing syndromes. Most of the latter (32, 68.1%) had inherited bone marrow failure syndromes, nine (19.1%) had inherited thrombocytopenia predisposing to leukemia, and three each (6.4%) had predisposition to myelodysplastic syndrome or congenital neutropenia. Twelve patients had cytopenias with no known leukemia predisposition, including nine children with inherited thrombocytopenia and three with congenital neutropenia. In summary, almost one third of 189 children referred with persistent cytopenias had an underlying inherited disorder; 79.7% of whom had a germline predisposition to leukemia. Precise diagnosis of children with cytopenias should direct follow-up and management programs and may positively impact disease outcome.
KW - Anemia, Aplastic/genetics
KW - Child
KW - Congenital Bone Marrow Failure Syndromes
KW - Disease Susceptibility
KW - Humans
KW - Leukemia
KW - Myelodysplastic Syndromes/diagnosis
KW - Neutropenia/congenital
KW - Thrombocytopenia/diagnosis
UR - http://www.scopus.com/inward/record.url?scp=85137137708&partnerID=8YFLogxK
U2 - https://doi.org/10.3324/haematol.2021.280116
DO - https://doi.org/10.3324/haematol.2021.280116
M3 - مقالة
C2 - 35295078
SN - 0390-6078
VL - 107
SP - 2081
EP - 2095
JO - Haematologica
JF - Haematologica
IS - 9
ER -